Hoag Memorial Hospital Presbyterian   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Orange County CA United States (1952)

Organization Overview

First Clinical Trial
1992
NCT00002506
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Hoag Memorial Hospital, Newport Beach, CA | Hoag Memorial Hospital Presbyterian | Institute for Systems Biology | Lalita Pandit, MD | The Hoag Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Neoplasms (Phase 1)

Carcinoma, Renal Cell (Phase 2)

Central Nervous System Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Glioblastoma (Phase 2)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Nervous System Neoplasms (Phase 2)

Penile Neoplasms (Phase 2)

Plasmacytoma (Phase 2)

Precancerous Conditions (Phase 2)

Preleukemia (Phase 2)

Prostatic Neoplasms (Phase 2)

Skin Neoplasms (Phase 2)

Stroke (Phase 2)

Syndrome (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 21
  • # of Trial APIs: 25